Sightera Biosciences is an AI drug discovery spin-off that trains its models on patient-derived biological material to design new small molecules for oncology and fibrosis.
Create a free EquityFlow account to see Sightera Biosciences's 1 funding round, 3 investors, 12 similar companies.
Sign up free → Sign in